Liver injury after beginning antiretroviral therapy in HIV/hepatitis C virus co-infected patients is not related to immune reconstitution

AIDS

Volumn 16, Issue 10, 2002, Pages 1423-1425

  Martín Carbonero, Luz ^a   Núñez, Marina ^a   Ríos, Pilar ^a   Pérez Olmeda, Mayte ^a   González Lahoz, Juan ^a   Soriano, Vincent ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LIVER INJURY; LIVER TOXICITY; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; RISK FACTOR; BLOOD; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; LETTER; RETROSPECTIVE STUDY; TOXIC HEPATITIS; VIREMIA; VIROLOGY; VIRUS LOAD;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; FEMALE; HEPATITIS C; HEPATITIS, TOXIC; HIV INFECTIONS; HUMAN; MALE; RETROSPECTIVE STUDIES; RNA, VIRAL; VIRAL LOAD; VIREMIA; HUMANS;

EID: 0037024767     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200207050-00016     Document Type: Article

References (9)

1. Hepatotoxicity associated with antiretroviral therapy in adults infected with HIV and the role of hepatitis C or B virus infection
2. Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection
3. Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy
4. Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: An immune restoration disease?
5. Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy
6. Liver damage and kinetics of hepatitis C virus and HIV replication during the early phases of combination antiretroviral treatment
7. Tritherapy for HIV infection does not modify replication of hepatitis C virus in coinfected subjects
8. Inflammatory reactions in HIV-1 infected persons after initiation of highly active antiretroviral therapy
9. Increase in hepatitis C virus load in hemophiliacs during treatment with highly active antiretroviral therapy